Renalytix Plc
RENX.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | £9,683 | £15,053 | £117,393 | £86,909 |
| - Cash | £3,600 | £4,680 | £24,682 | £41,333 |
| + Debt | £8,300 | £8,535 | £12,150 | £12,342 |
| Enterprise Value | £14,383 | £18,908 | £104,861 | £57,918 |
| Revenue | £3,000 | £2,289 | £3,403 | £2,970 |
| % Growth | 31.1% | -32.7% | 14.6% | – |
| Gross Profit | £1,200 | £156 | £701 | £918 |
| % Margin | 40% | 6.8% | 20.6% | 30.9% |
| EBITDA | -£21,300 | -£28,521 | -£41,713 | -£52,694 |
| % Margin | -710% | -1,246% | -1,225.8% | -1,774.2% |
| Net Income | -£20,400 | -£33,456 | -£45,607 | -£45,276 |
| % Margin | -680% | -1,461.6% | -1,340.2% | -1,524.4% |
| EPS Diluted | -0.21 | -0.31 | -0.55 | -0.67 |
| % Growth | 32.3% | 43.6% | 17.9% | – |
| Operating Cash Flow | -£17,900 | -£30,111 | -£32,674 | -£45,745 |
| Capital Expenditures | £0 | -£4 | £0 | -£694 |
| Free Cash Flow | -£17,900 | -£30,115 | -£32,674 | -£46,439 |